APA (7th ed.) Citation

S, N., W, W., N, K., CM, B., J, S., YT, C., . . . TG, B. (2022). Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer. The Journal of clinical investigation, 132(13), . https://doi.org/10.1172/JCI145099

Chicago Style (17th ed.) Citation

S, Nanjo, et al. "Deficiency of the Splicing Factor RBM10 Limits EGFR Inhibitor Response in EGFR-mutant Lung Cancer." The Journal of Clinical Investigation 132, no. 13 (2022). https://doi.org/10.1172/JCI145099.

MLA (9th ed.) Citation

S, Nanjo, et al. "Deficiency of the Splicing Factor RBM10 Limits EGFR Inhibitor Response in EGFR-mutant Lung Cancer." The Journal of Clinical Investigation, vol. 132, no. 13, 2022, https://doi.org/10.1172/JCI145099.